The spice in France: mixed herbs containing synthetic cannabinoids

被引:2
|
作者
Schlatter, Joel [1 ]
Chiadmi, Fouad [1 ]
Chariot, Patrick [2 ,3 ]
机构
[1] Hop Jean Verdier AP HP, Lab Toxicol Med, Bondy, France
[2] Hop Jean Verdier AP HP, Serv Med Legale, Bondy, France
[3] Univ Paris 13, Inst Rech Interdisciplinaire Enjeux Sociaux, IRIS, UMR 8156 723, F-93430 Villetaneuse, France
关键词
Spice; synthetic cannabinoids; forensic toxicology; CANNABIMIMETIC INDOLES; RECEPTOR; CB1; PHARMACOLOGY; CLASSIFICATION; CP-47,497; OLEAMIDE; AGONIST; ANALOGS; DRUGS;
D O I
10.1684/abc.2012.0728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Smokable herbal mixtures under the brand name Spice were first sold on the Internet and in various specialised shops in 2006 or earlier. When smoked, the Spice products have effects similar to those of cannabis. Forensic investigations were undertaken by German and Austrian authorities in order to identify the psychoactive ingredients of Spice. A new psychoactive substance JWH-018 has been identified in Spice products. JWH-018 was first synthesized in 1995 and produces effects similar to those THC. Subsequently, the synthetic cannabinoid CP 47,497 was also identified. Outside of Europe, the United States Drug Enforcement Administration reported that another potent synthetic cannabinoid, HU-210, had been found. Since 2009, other synthetic cannabinoids were identified in Europe. None of the above-mentioned synthetic cannabinoids is internationally controlled as a drug and there is no information on any of them having been authorised as a medicinal product in the European Union. There are no officially published safety data and little is known about their effects in humans. Some of the characteristics of these compounds, e.g. volatility and activity in small doses, are likely to present further analytical and toxicological challenges. Responding to potential health concerns, Europe has taken legal actions to ban or otherwise control Spice products and related compounds.
引用
收藏
页码:413 / 422
页数:10
相关论文
共 50 条
  • [21] Acute Intoxications by Herbal Blends Containing Synthetic Cannabinoids
    Hermanns-Clausen, M.
    Kneisel, S.
    Auwaerter, V
    CLINICAL TOXICOLOGY, 2012, 50 (04) : 340 - 340
  • [22] Focus on Cannabinoids and Synthetic Cannabinoids
    Le Boisselier, R.
    Alexandre, J.
    Lelong-Boulouard, V.
    Debruyne, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (02) : 220 - 229
  • [23] Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice
    Kemp, Ann M.
    Clark, Molly S.
    Dobbs, Thomas
    Galli, Robert
    Sherman, Justin
    Cox, Robert
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (03): : 240 - +
  • [24] Conjugation of synthetic cannabinoids in K2/Spice by human UDP-glucuronosyltransferase (UGTs)
    Radominska-Pandya, Anna
    Yiew, Kan Hui Nicole
    Bratton, Stacie M.
    Le, Vi-Huyen
    Gallus-Zawada, Anna
    Moran, Cindy
    James, Laura P.
    Moran, Jeffery H.
    FASEB JOURNAL, 2011, 25
  • [25] Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
    Seely, Kathryn A.
    Lapoint, Jeff
    Moran, Jeffery H.
    Fattore, Liana
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (02): : 234 - 243
  • [26] THE SPICE CORNER - NEWS ON HERBS AND SPICES
    ANTENEN, U
    ALIMENTA, 1992, 31 (05): : 97 - 98
  • [27] Analytical Methods for Herbal Products Containing Synthetic Cannabinoids: A Review
    Kumar, Sachil
    Baggi, Tulsidas R.
    FORENSIC CHEMISTRY, 2022, 27
  • [28] Synthetic cannabinoids
    Antoniou, Tony
    Juurlink, David N.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (03) : 210 - 210
  • [29] Synthetic Cannabinoids
    Mills, Brooke
    Yepes, Andres
    Nugent, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (01): : 59 - 62
  • [30] Synthetic cannabinoids
    Bilici, Rabia
    NORTHERN CLINICS OF ISTANBUL, 2014, 1 (02) : 121 - 126